These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
316 related items for PubMed ID: 8324618
41. Birth control vaccines: the progress continues. Prog Hum Reprod Res; 1992; (22):4-5. PubMed ID: 12286012 [Abstract] [Full Text] [Related]
42. Zona pellucida: current status as a candidate antigen for contraceptive vaccine development. Sacco AG. Am J Reprod Immunol Microbiol; 1987 Dec; 15(4):122-30. PubMed ID: 3324778 [Abstract] [Full Text] [Related]
43. A birth control vaccine is on the horizon for family planning. Talwar GP, Singh O, Pal R, Chatterjee N, Upadhyay SN, Kaushic C, Garg S, Kaur R, Singh M, Chandrasekhar S. Ann Med; 1993 Apr; 25(2):207-12. PubMed ID: 7683889 [Abstract] [Full Text] [Related]
44. Prospects of zona pellucida glycoproteins as immunogens for contraceptive vaccine. Gupta SK, Jethanandani P, Afzalpurkar A, Kaul R, Santhanam R. Hum Reprod Update; 1997 Apr; 3(4):311-24. PubMed ID: 9459277 [Abstract] [Full Text] [Related]
46. Evaluation of the contraceptive potential of recombinant human ZP3 and human ZP3 peptides in a primate model: their safety and efficacy. Paterson M, Wilson MR, Morris KD, van Duin M, Aitken RJ. Am J Reprod Immunol; 1998 Sep; 40(3):198-209. PubMed ID: 9764365 [Abstract] [Full Text] [Related]
48. Antibody response against three epitopic domains on human chorionic gonadotropin (hCG) in women and rodents immunized with a beta hCG-based immunocontraceptive vaccine. Deshmukh US, Talwar GP, Gupta SK. J Clin Immunol; 1994 May; 14(3):162-8. PubMed ID: 7523433 [Abstract] [Full Text] [Related]
50. Birth control vaccines and immunological approaches to the therapy of noninfectious diseases. Stevens VC. Infect Dis Clin North Am; 1990 Jun; 4(2):343-54. PubMed ID: 2345290 [Abstract] [Full Text] [Related]
51. An improved immunogen for anti-human chorionic gonadotropin vaccine eliciting antibodies reactive with a conformation native to the hormone without cross-reaction with human follicle stimulating hormone and human thyroid stimulating hormone. Talwar GP, Singh O, Rao LV. J Reprod Immunol; 1988 Dec; 14(3):203-12. PubMed ID: 3147333 [Abstract] [Full Text] [Related]
53. Tetanus vaccine may be laced with anti-fertility drug. International / developing countries. Vaccine Wkly; 2003 Aug; ():9-10. PubMed ID: 12346214 [Abstract] [Full Text] [Related]
54. The development of a contraceptive vaccine by purification of antigens from gametes. Isojima S, Koyama K, Takada Y, Shigeta M, Tsuji Y, Hasegawa A. Am J Reprod Immunol Microbiol; 1986 Mar; 10(3):90-2. PubMed ID: 3717477 [Abstract] [Full Text] [Related]
56. Immunological aspects of sperm receptors on the zona pellucida of mammalian eggs. Dunbar BS, Shivers CA. Immunol Commun; 1976 Mar; 5(5):375-85. PubMed ID: 61169 [Abstract] [Full Text] [Related]
58. Options for immunocontraception and issues to be addressed in the development of birth control vaccines. Griffin PD. Scand J Immunol Suppl; 1992 Mar; 11():111-7. PubMed ID: 1514024 [Abstract] [Full Text] [Related]
59. Immunogenicity and contraceptive potential of a human zona pellucida 3 peptide vaccine. Bagavant H, Fusi FM, Baisch J, Kurth B, David CS, Tung KS. Biol Reprod; 1997 Mar; 56(3):764-70. PubMed ID: 9047023 [Abstract] [Full Text] [Related]
60. Development of antisperm contraceptive vaccine for humans: why and how? Naz R, Menge A. Hum Reprod; 1990 Jul; 5(5):511-8. PubMed ID: 2203802 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]